ARA-290: Benefits & Research
Part of the ARA-290 Complete Guide
Research Peptides
Advertiser link — we may earn a commission at no extra cost to you.
Neuropathic Pain Relief
Phase 2 trials demonstrated ARA-290 improved neuropathic pain scores and increased small fiber nerve density in patients with sarcoidosis-associated neuropathy. Corneal confocal microscopy showed measurable nerve fiber regeneration — objective evidence of structural nerve repair.
Tissue-Protective Effects
ARA-290 activates the innate repair receptor (IRR), triggering anti-apoptotic and anti-inflammatory cascades. The IRR is expressed on stressed and damaged cells, making ARA-290's effects selectively targeted to injured tissue rather than healthy cells.
Metabolic Improvements
Studies in type 2 diabetes patients showed ARA-290 improved metabolic control alongside neuropathic symptom relief. The EPO-derived pathway has established connections to metabolic regulation beyond erythropoiesis.